CY1816A - BMY - 41950 antitumor antibiotic - Google Patents
BMY - 41950 antitumor antibioticInfo
- Publication number
- CY1816A CY1816A CY181695A CY181695A CY1816A CY 1816 A CY1816 A CY 1816A CY 181695 A CY181695 A CY 181695A CY 181695 A CY181695 A CY 181695A CY 1816 A CY1816 A CY 1816A
- Authority
- CY
- Cyprus
- Prior art keywords
- bmy
- antitumor antibiotic
- antibiotic
- antitumor
- atcc
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
- Y10S435/898—Streptomyces hygroscopicus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32792989A | 1989-03-23 | 1989-03-23 | |
US07/482,364 US5015578A (en) | 1989-03-23 | 1990-02-20 | BMY-41950 antitumor antibiotic |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1816A true CY1816A (en) | 1995-10-20 |
Family
ID=26986136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY181695A CY1816A (en) | 1989-03-23 | 1995-10-20 | BMY - 41950 antitumor antibiotic |
Country Status (10)
Country | Link |
---|---|
US (1) | US5015578A (ja) |
EP (1) | EP0388962B1 (ja) |
JP (1) | JPH07624B2 (ja) |
AT (1) | ATE111476T1 (ja) |
CY (1) | CY1816A (ja) |
DE (1) | DE69012384T2 (ja) |
DK (1) | DK0388962T3 (ja) |
ES (1) | ES2058645T3 (ja) |
HK (1) | HK23695A (ja) |
SG (1) | SG163194G (ja) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242814A (en) * | 1989-10-10 | 1993-09-07 | Eli Lilly And Company | Polyether antibiotic |
US4973552A (en) * | 1990-02-20 | 1990-11-27 | Bristol-Meyers Squibb Company | Staurosporine fermentation process |
US5158938A (en) * | 1990-03-06 | 1992-10-27 | Bristol-Myers Squibb Company | Rebeccamycin |
US5478813A (en) * | 1990-05-11 | 1995-12-26 | Banyu Pharmaceutical Co., Ltd. | Antitumor substance BE-13793C derivatives |
US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5589365A (en) * | 1991-11-29 | 1996-12-31 | Banyu Pharmaceutical Co., Ltd. | Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms |
US5591842A (en) * | 1991-11-29 | 1997-01-07 | Banyu Pharmaceutical Co., Ltd. | Indolopyrrolocarbazole derivatives |
US5437996A (en) * | 1992-11-24 | 1995-08-01 | Banyu Pharmaceutical Co., Ltd. | Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives |
DE69326388T2 (de) * | 1992-06-22 | 1999-12-30 | Kyowa Hakko Kogyo Co., Ltd. | Verfahren zur Herstellung von Staurosporin-Derivaten |
US6306421B1 (en) | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6663881B2 (en) | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
ATE485825T1 (de) | 1993-01-28 | 2010-11-15 | Boston Scient Ltd | Therapeutische inhibitoren der zellen der glatten gefässmuskulatur |
US5804564A (en) * | 1994-05-09 | 1998-09-08 | Banyu Pharmaceutical Co., Ltd. | Antitumor indolopyrrolocarbazole derivatives |
US5922860A (en) * | 1994-05-09 | 1999-07-13 | Banyu Pharmaceutical Co., Ltd. | Antitumor indolopyrrolocarbazole derivatives |
EP0975340B2 (en) | 1997-03-31 | 2009-10-28 | Boston Scientific Limited | Therapeutic inhibitor of vascular smooth muscle cells |
CO4940430A1 (es) * | 1997-07-07 | 2000-07-24 | Novartis Ag | Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales |
US6284783B1 (en) | 1999-06-09 | 2001-09-04 | The Uab Research Foundation | Use of bisindolylmaleimide compounds to induce Fas-mediated apoptosis |
FR2801054B1 (fr) * | 1999-11-17 | 2003-06-13 | Adir | Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2004094645A1 (en) * | 2003-04-22 | 2004-11-04 | Lonza Ag | Process for the recovery of staurosporine from a fermentation broth |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5373501A (en) * | 1976-12-11 | 1978-06-30 | Kitasato Inst | Novel antibiotics amm2282 and process for preparing same |
US4390546A (en) * | 1981-12-07 | 1983-06-28 | Merck & Co., Inc. | Antiparasitic macrolide from a strain of Streptomyces hygroscopicus |
US4524145A (en) * | 1984-09-04 | 1985-06-18 | Bristol-Myers Company | 4'-Deschlororebeccamycin pharmaceutical composition and method of use |
US4743594A (en) * | 1984-09-17 | 1988-05-10 | Schering Corporation | Antibiotic, antitumor compounds and their use |
JPS62220196A (ja) * | 1986-03-20 | 1987-09-28 | Kyowa Hakko Kogyo Co Ltd | 新規物質ucn―01 |
US4785085A (en) * | 1986-11-21 | 1988-11-15 | Bristol-Myers Company | Rebeccamycin analogs |
DE3752123T2 (de) * | 1987-03-09 | 1998-05-14 | Kyowa Hakko Kogyo Kk | Derivate des physiologisch aktiven mittels k-252 |
-
1990
- 1990-02-20 US US07/482,364 patent/US5015578A/en not_active Expired - Lifetime
- 1990-03-22 DE DE69012384T patent/DE69012384T2/de not_active Expired - Lifetime
- 1990-03-22 EP EP90105446A patent/EP0388962B1/en not_active Expired - Lifetime
- 1990-03-22 AT AT90105446T patent/ATE111476T1/de not_active IP Right Cessation
- 1990-03-22 JP JP2073173A patent/JPH07624B2/ja not_active Expired - Lifetime
- 1990-03-22 DK DK90105446.0T patent/DK0388962T3/da active
- 1990-03-22 ES ES90105446T patent/ES2058645T3/es not_active Expired - Lifetime
-
1994
- 1994-11-14 SG SG163194A patent/SG163194G/en unknown
-
1995
- 1995-02-23 HK HK23695A patent/HK23695A/xx not_active IP Right Cessation
- 1995-10-20 CY CY181695A patent/CY1816A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0388962A3 (en) | 1991-01-16 |
ES2058645T3 (es) | 1994-11-01 |
HK23695A (en) | 1995-03-03 |
US5015578A (en) | 1991-05-14 |
DE69012384T2 (de) | 1995-02-16 |
DK0388962T3 (da) | 1994-10-17 |
JPH03215428A (ja) | 1991-09-20 |
EP0388962B1 (en) | 1994-09-14 |
DE69012384D1 (de) | 1994-10-20 |
ATE111476T1 (de) | 1994-09-15 |
SG163194G (en) | 1995-04-28 |
JPH07624B2 (ja) | 1995-01-11 |
EP0388962A2 (en) | 1990-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1816A (en) | BMY - 41950 antitumor antibiotic | |
GB8804440D0 (en) | Antiparasitic agents | |
EP0670317A4 (ja) | ||
EP0345735A3 (en) | Glycoside antibiotics bu-3608d and bu-3608e | |
AU3104189A (en) | Bu-3862t antitumor antibiotic | |
GR3006381T3 (ja) | ||
AU7649796A (en) | Compound gexi | |
EP0376609A3 (en) | Antibiotic a80915 and process for its production | |
AU563466B2 (en) | Antibiotic a 51568 factors a and b | |
ZA893295B (en) | Antibiotic compounds | |
AU4741785A (en) | At 2433 antibiotic | |
GR81465B (ja) | ||
NZ244198A (en) | Antibiotic compound ll-e19020 alpha 1 and its microbiological preparation | |
NZ244199A (en) | Antibiotic compound ll-e19020 gamma its preparation and growth-promoting compositions | |
AU2057392A (en) | Polyglucosides obtained from hydroxyalkylsorbitol |